Related Experiment Video
Updated: Aug 17, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing
Hamid Mehenni1, Nathalie Lin-Marq, Karine Buchet-Poyau
1Département de Biologie Cellulaire, Université de Genève, 1211 Genève 4, Switzerland.
Abstract:
Germline mutations of the LKB1 (STK11) tumor suppressor gene lead to Peutz-Jeghers syndrome (PJS) and predisposition to cancer. LKB1 encodes a serine/threonine kinase generally inactivated in PJS patients. We identified the dual phosphatase and tumor suppressor protein PTEN as an LKB1-interacting protein. Several LKB1 point mutations associated with PJS disrupt the interaction with PTEN suggesting that the loss of this interaction might contribute to PJS. Although PTEN and LKB1 are predominantly cytoplasmic and nuclear, respectively, their interaction leads to a cytoplasmic relocalization of LKB1. In addition, we show that PTEN is a substrate of the kinase LKB1 in vitro. As PTEN is a dual phosphatase mutated in autosomal inherited disorders with phenotypes similar to those of PJS (Bannayan-Riley-Ruvalcaba syndrome and Cowden disease), our study suggests a functional link between the proteins involved in different hamartomatous polyposis syndromes and emphasizes the central role played by LKB1 as a tumor suppressor in the small intestine.
Insights
Germline mutations in the LKB1 gene cause Peutz-Jeghers syndrome (PJS). This study reveals PTEN interacts with LKB1, and disrupted interaction contributes to PJS and cancer predisposition.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Germline mutations in the LKB1 (STK11) tumor suppressor gene are linked to Peutz-Jeghers syndrome (PJS), a condition predisposing individuals to cancer.
- LKB1, a serine/threonine kinase, is frequently inactivated in PJS patients.
Purpose of the Study:
- To investigate the functional relationship between LKB1 and PTEN, a known tumor suppressor.
- To determine if the interaction between LKB1 and PTEN is disrupted in Peutz-Jeghers syndrome.
Main Methods:
- Protein-protein interaction assays to identify LKB1-interacting partners.
- Analysis of LKB1 mutations found in PJS patients to assess their impact on PTEN interaction.
- In vitro kinase assays to determine if PTEN is a substrate of LKB1.
Main Results:
- The dual phosphatase and tumor suppressor PTEN was identified as an LKB1-interacting protein.
- Several LKB1 point mutations associated with PJS were found to disrupt the interaction with PTEN.
- PTEN was confirmed as a substrate of LKB1 kinase in vitro.
- The interaction between PTEN and LKB1 promotes cytoplasmic relocalization of LKB1.
Conclusions:
- The disruption of the LKB1-PTEN interaction may contribute to the pathogenesis of Peutz-Jeghers syndrome.
- This study suggests a functional link between LKB1 and PTEN in hamartomatous polyposis syndromes.
- LKB1 plays a crucial role as a tumor suppressor, particularly in the small intestine.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
